Skip to Main Content

Paper Details

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
PLoS Pathog
22
2020
Author NameAffiliation
Ann C CollierUniversity of Washington
  • 1 - 1

Datasets

Release 1.2